BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Paragon Biomedical, Inc. Electronic Data Capture Expertise Expands


3/22/2011 8:28:49 AM

IRVINE, CA--(Marketwire - March 22, 2011) -

Paragon Biomedical, a leader of global CRO solutions to the biopharmaceutical and medical device industries, today announced they have partnered with Medrio, an electronic data capture (EDC) software company, further adding to Paragon's expertise in managing EDC-driven clinical programs.

"Paragon has successfully worked with Medrio for more than two years, conducting numerous studies together," says Marianne Plaunt, Vice President, Global Project Services, which includes Paragon's data management, statistical, and medical writing services. "While Paragon will partner with any of its Sponsors' EDC providers and has, in fact, worked with all Top 5 EDC providers, Medrio's open and flexible system allows Paragon's rapid study start-up timeline to average 6 weeks compared to the industry average of 12 weeks. We are proud to say 100% of our data operations studies over the past three years have either locked early or on-time, including a recently completed 2,500 patient global trial where 300 case books were locked in four working days."

Mike Novotny, Chief Executive Officer of Medrio, adds, "Paragon has been a key partner in Medrio's growth and expansion. Paragon Biomedical's expertise with Medrio provides important efficiencies for Sponsors because Paragon provides a single point of contact for all services, which enables Medrio to focus on building great software. Results include faster build times, lower costs, and better implementation for sites."

About Medrio
Medrio provides a fully-hosted eClinical system that CROs or Sponsors configure without reliance on software programmers. The result is a vast improvement in 1) Deployment Time: studies online in days rather than weeks, and mid-study changes in hours; 2) Cost: low monthly subscription per study; and 3) Control: no dependence on staff from the eClinical vendor.

Medrio supports Phase I through IV trials within a secure, regulatory-compliant environment.

Please visit Medrio on the web at www.medrio.com.

About Paragon Biomedical
Paragon Biomedical is a global, full-service clinical research organization (CRO) providing Phase I through IV clinical research services and support to the world's biopharmaceutical and medical device companies.

Paragon is a woman-owned CRO certified by the National Women Business Owners Corporation (NWBOC) and the Women's Business Enterprise National Council (WBENC).

Please visit Paragon Biomedical on the web at www.paragonbiomedical.com.


CONTACT:
Clareece West
Paragon Biomedical, Inc.
9685 Research Drive
Irvine, CA 92618
Phone: +1 913 322 6794
www.paragonbiomedical.com
Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES